Proportional consumption of (A) parenteral and (B) oral antibiotics by AWaRe categorization among all admissions (n = 91,960) of all inpatients (n = 60,228) between 2019 and 2020.

Sinto, Robert; Lie, Khie Chen; Setiati, Siti; Suwarto, Suhendro; Nelwan, Erni J.; Karyanti, Mulya Rahma; Karuniawati, Anis; Djumaryo, Dean Handimulya; Prayitno, Ari; Sumariyono, Sumariyono; Sharland, Mike; Moore, Catrin E.; Hamers, Raph L.; Day, Nicholas P. J.; Limmathurotsakul, Direk

doi:10.1371/journal.pone.0297405.s001

pone.0297405.s001.docx (292.21 kB)

Proportional consumption of (A) parenteral and (B) oral antibiotics by AWaRe categorization among all admissions (n = 91,960) of all inpatients (n = 60,228) between 2019 and 2020.

journal contribution

posted on 2024-03-07, 18:46 authored by Robert Sinto, Khie Chen Lie, Siti Setiati, Suhendro Suwarto, Erni J. Nelwan, Mulya Rahma Karyanti, Anis Karuniawati, Dean Handimulya Djumaryo, Ari Prayitno, Sumariyono Sumariyono, Mike Sharland, Catrin E. Moore, Raph L. Hamers, Nicholas P. J. Day, Direk Limmathurotsakul

For this figure, antibiotics in the Watch category was divided to Watch and Watch+. Watch+ category comprises antibiotics in the Watch category with anti-MRSA activity (e.g. vancomycin) or antipseudomonal activity (e.g. antipseudomonal cephalosporin, antipseudomonal penicillin and carbapenems).

(DOCX)

Proportional consumption of (A) parenteral and (B) oral antibiotics by AWaRe categorization among all admissions (n = 91,960) of all inpatients (n = 60,228) between 2019 and 2020.

History

Usage metrics

Categories

Keywords

Licence

Exports